Kimberly-Clark (NYSE:KMB) Price Target Increased to $136.00 by Analysts at Wells Fargo & Company

Kimberly-Clark (NYSE:KMB) had its price target lifted by equities researchers at Wells Fargo & Company from $131.00 to $136.00 in a note issued to investors on Wednesday, Benzinga reports. The brokerage presently has an “equal weight” rating on the stock. Wells Fargo & Company‘s target price would indicate a potential downside of 0.32% from the company’s current price.

Several other research analysts have also recently weighed in on the stock. StockNews.com raised shares of Kimberly-Clark from a “hold” rating to a “buy” rating in a report on Thursday, April 11th. Barclays increased their price target on Kimberly-Clark from $124.00 to $132.00 and gave the company an “equal weight” rating in a report on Friday, April 12th. Evercore ISI raised Kimberly-Clark from an “in-line” rating to an “outperform” rating and lifted their price objective for the stock from $133.00 to $150.00 in a report on Thursday, March 28th. The Goldman Sachs Group initiated coverage on Kimberly-Clark in a report on Friday, March 1st. They issued a “buy” rating and a $135.00 target price on the stock. Finally, Piper Sandler boosted their price target on Kimberly-Clark from $145.00 to $152.00 and gave the company an “overweight” rating in a research note on Thursday, March 28th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $135.50.

Kimberly-Clark Price Performance

Shares of KMB opened at $136.43 on Wednesday. Kimberly-Clark has a twelve month low of $116.32 and a twelve month high of $147.09. The company has a market capitalization of $45.96 billion, a P/E ratio of 25.08, a price-to-earnings-growth ratio of 4.05 and a beta of 0.40. The firm has a 50 day moving average of $125.53 and a 200 day moving average of $122.75. The company has a quick ratio of 0.54, a current ratio of 0.81 and a debt-to-equity ratio of 6.05.

Kimberly-Clark (NYSE:KMB) last announced its quarterly earnings results on Tuesday, April 23rd. The company reported $2.01 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.61 by $0.40. Kimberly-Clark had a return on equity of 250.28% and a net margin of 9.05%. The firm had revenue of $5.15 billion for the quarter, compared to the consensus estimate of $5.08 billion. During the same period in the prior year, the company posted $1.67 earnings per share. The company’s quarterly revenue was down .9% on a year-over-year basis. As a group, equities research analysts anticipate that Kimberly-Clark will post 6.84 earnings per share for the current fiscal year.

Insider Transactions at Kimberly-Clark

In other Kimberly-Clark news, Director Mark T. Smucker acquired 827 shares of the stock in a transaction dated Monday, January 29th. The shares were acquired at an average cost of $120.98 per share, for a total transaction of $100,050.46. Following the completion of the transaction, the director now directly owns 827 shares of the company’s stock, valued at $100,050.46. The purchase was disclosed in a legal filing with the SEC, which is available at this hyperlink. In related news, insider Paula Ramos sold 10,178 shares of the stock in a transaction that occurred on Wednesday, April 24th. The stock was sold at an average price of $137.17, for a total transaction of $1,396,116.26. Following the completion of the transaction, the insider now directly owns 795 shares of the company’s stock, valued at $109,050.15. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Mark T. Smucker bought 827 shares of the stock in a transaction dated Monday, January 29th. The shares were purchased at an average price of $120.98 per share, with a total value of $100,050.46. Following the completion of the transaction, the director now directly owns 827 shares in the company, valued at approximately $100,050.46. The disclosure for this purchase can be found here. Corporate insiders own 0.62% of the company’s stock.

Institutional Trading of Kimberly-Clark

Large investors have recently made changes to their positions in the business. Exchange Traded Concepts LLC lifted its stake in shares of Kimberly-Clark by 140.7% in the 3rd quarter. Exchange Traded Concepts LLC now owns 32,265 shares of the company’s stock valued at $3,899,000 after purchasing an additional 18,860 shares during the last quarter. Private Trust Co. NA boosted its stake in Kimberly-Clark by 2.5% during the third quarter. Private Trust Co. NA now owns 6,467 shares of the company’s stock worth $782,000 after buying an additional 160 shares during the period. Ballast Inc. increased its position in Kimberly-Clark by 3.2% during the third quarter. Ballast Inc. now owns 9,558 shares of the company’s stock valued at $1,155,000 after acquiring an additional 298 shares during the last quarter. SS&H Financial Advisors Inc. purchased a new stake in shares of Kimberly-Clark in the third quarter valued at $870,000. Finally, Keudell Morrison Wealth Management lifted its holdings in shares of Kimberly-Clark by 5.9% in the 3rd quarter. Keudell Morrison Wealth Management now owns 3,898 shares of the company’s stock worth $471,000 after acquiring an additional 216 shares during the last quarter. 76.29% of the stock is currently owned by institutional investors.

Kimberly-Clark Company Profile

Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products in the United States. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The company's Personal Care segment offers disposable diapers, training and youth pants, swimpants, baby wipes, feminine and incontinence care products, reusable underwear, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Thinx, Poise, Depend, Plenitud, Softex, and other brand names.